QBIO Stock - Q BioMed Inc.
Unlock GoAI Insights for QBIO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $284,352 | $195,597 | $30,000 | N/A | N/A |
| Gross Profit | $-8,988 | $-51,249 | $-296,009 | $-50,000 | N/A |
| Gross Margin | -3.2% | -26.2% | -986.7% | N/A | N/A |
| Operating Income | $-3,445,616 | $-7,388,565 | $-13,145,414 | $-8,019,958 | $-9,019,673 |
| Net Income | $-2,052,093 | $-8,240,550 | $-13,492,191 | $-10,279,730 | $-9,270,777 |
| Net Margin | -721.7% | -4213.0% | -44974.0% | N/A | N/A |
| EPS | $-0.08 | $-0.33 | $-0.65 | $-0.78 | $-0.67 |
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutics to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.
Visit WebsiteEarnings History & Surprises
QBIOEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Feb 21, 2025 | — | — | — | — |
Q1 2025 | Jan 7, 2025 | — | — | — | — |
Q4 2024 | Oct 28, 2024 | — | — | — | — |
Q2 2024 | May 31, 2024 | — | — | — | — |
Q2 2024 | Apr 26, 2024 | — | — | — | — |
Q4 2023 | Dec 1, 2023 | — | — | — | — |
Q3 2023 | Aug 24, 2023 | — | — | — | — |
Q2 2023 | Jun 16, 2023 | — | $-0.02 | — | — |
Q2 2023 | May 28, 2023 | — | — | — | — |
Q2 2023 | May 26, 2023 | $0.04 | $0.08 | +100.0% | ✓ BEAT |
Q4 2022 | Nov 3, 2022 | $-0.06 | $-0.03 | +50.0% | ✓ BEAT |
Q3 2022 | Jul 28, 2022 | $-0.08 | $-0.06 | +25.0% | ✓ BEAT |
Q2 2022 | Apr 14, 2022 | $-0.09 | $-0.08 | +11.1% | ✓ BEAT |
Q1 2022 | Feb 28, 2022 | $-0.11 | $-0.08 | +27.3% | ✓ BEAT |
Q4 2021 | Oct 15, 2021 | $-0.12 | $-0.07 | +41.7% | ✓ BEAT |
Q3 2021 | Jul 15, 2021 | $-0.12 | $-0.08 | +33.3% | ✓ BEAT |
Q2 2021 | Apr 14, 2021 | $-0.14 | $-0.11 | +21.4% | ✓ BEAT |
Q1 2021 | Mar 1, 2021 | $-0.08 | $-0.15 | -87.5% | ✗ MISS |
Q4 2020 | Oct 14, 2020 | $-0.09 | $-0.11 | -22.2% | ✗ MISS |
Q3 2020 | Jul 15, 2020 | $-0.13 | $-0.11 | +15.4% | ✓ BEAT |
Latest News
Frequently Asked Questions about QBIO
What is QBIO's current stock price?
What is the analyst price target for QBIO?
What sector is Q BioMed Inc. in?
What is QBIO's market cap?
Does QBIO pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to QBIO for comparison